Evidence map›Paper›PMID 35018825›Full record

ReviewTissue engineering. Part B, Reviews2022

Optimization of Application-Driven Development of

Julie B Strickland, Katie Davis-Anderson, Sofiya Micheva-Viteva, Scott Twary, Rashi Iyer, Jennifer Foster Harris, Emilia A Solomon

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Tissue engineering. Part B, Reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Hyaluronic Acid-Based Bioink for Anisotropic Neural Tissue Cryobioprinting.International journal of extreme manufacturing · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Julie B StricklandBioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.ORCID 0000-0002-7160-6910
Katie Davis-AndersonBioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.ORCID 0000-0003-0549-2844
Sofiya Micheva-VitevaBioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.ORCID 0000-0002-2693-4333
Scott TwaryBioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.ORCID 0000-0002-5074-6658
Rashi IyerInformation System and Modeling, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
Jennifer Foster HarrisBioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.ORCID 0000-0001-7406-1904
Emilia A SolomonBioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.ORCID 0000-0003-0265-9792
Los Alamos National Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuromuscular junctions (NMJs) are specialized synapses responsible for signal transduction between motor neurons (MNs) and skeletal muscle tissue. Malfunction at this site can result from developmental disorders, toxic environmental exposures, and neurodegenerative diseases leading to severe neurological dysfunction. Exploring these conditions in human or animal subjects is restricted by ethical concerns and confounding environmental factors. Therefore,

Indexed as

Motor NeuronsNeuromuscular JunctionAnimalsCell DifferentiationHumansMuscle, SkeletalTissue Engineeringbioengineeringdrug screeninghigh-throughput screeningmotor neuronsneuromuscular junction

Identifiers

PMID35018825
PMCPMC9805869
OpenAlexW4206486443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.